Back

Pregnancy protection in women of child-bearing age prescribed ACE inhibitors, ARBs or statins - A nationwide cohort study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Drug interactions, efficacy, and safety Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sebastian Kinnberg Nielsen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

7 More presentations in this session

Presentation thumbnail
Adverse cardiovascular outcomes due to potential drug-drug interactions in statin therapy: a population-based study
Ms A. Lai (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity
Mr J. Lee (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Development of a cardiotoxicity evaluation system using a Heart-on-a-Chip Microdevice with aligned fiber device
Doctor K. Murata (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Drug-drug interactions of empagliflozin and dapagliflozin
Professor C. Stoellberger (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Choosing the most effective and safest P2Y12 Inhibitor for use in >70-year-old acute coronary syndrome patients: a network meta-analysis
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Drug interactions, efficacy, and safety

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Effects on reduction of morbidity and mortality in ACHD population of childbearing age as a result of ESC Guidelines
thumbnail
Congress Presentation
Maternal and fetal outcomes of various lipid-lowering treatment regimens during pregnancy: insights from the czech national registry 2012-2023
thumbnail
Congress Presentation
ACE inhibitor and angiotensin receptor blocker use during pregnancy: data from the ESC Registry of pregnancy and cardiac disease (ROPAC)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources